ENTRY       D10557                      Drug
NAME        Evolocumab (USAN/INN);
            Evolocumab (genetical recombination) (JAN);
            Repatha (TN)
PRODUCT     REPATHA (Amgen USA)
            REPATHA (Amgen)
FORMULA     C6242H9648N1668O1996S56
EXACT_MASS  141700.9089
MOL_WEIGHT  141789.0125
SEQUENCE    (Heavy chain)
            EVQLVQSGAE VKKPGASVKV SCKASGYTLT SYGISWVRQA PGQGLEWMGW VSFYNGNTNY
            AQKLQGRGTM TTDPSTSTAY MELRSLRSDD TAVYYCARGY GMDVWGQGTT VTVSSASTKG
            PSVFPLAPCS RSTSESTAAL GCLVKDYFPE PVTVSWNSGA LTSGVHTFPA VLQSSGLYSL
            SSVVTVPSSN FGTQTYTCNV DHKPSNTKVD KTVERKCCVE CPPCPAPPVA GPSVFLFPPK
            PKDTLMISRT PEVTCVVVDV SHEDPEVQFN WYVDGVEVHN AKTKPREEQF NSTFRVVSVL
            TVVHQDWLNG KEYKCKVSNK GLPAPIEKTI SKTKGQPREP QVYTLPPSRE EMTKNQVSLT
            CLVKGFYPSD IAVEWESNGQ PENNYKTTPP MLDSDGSFFL YSKLTVDKSR WQQGNVFSCS
            VMHEALHNHY TQKSLSLSPG K
            (Light chain)
            ESALTQPASV SGSPGQSITI SCTGTSSDVG GYNSVSWYQQ HPGKAPKLMI YEVSNRPSGV
            SNRFSGSKSG NTASLTISGL QAEDEADYYC NSYTSTSMVF GGGTKLTVLG QPKAAPSVTL
            FPPSSEELQA NKATLVCLIS DFYPGAVTVA WKADSSPVKA GVETTTPSKQ SNNKYAASSY
            LSLTPEQWKS HRSYSCQVTH EGSTVEKTVA PTECS
            (Disulfide bridge: H22-H96, H129-L124, H142-H198, H217-H'217, H218-H'218, H221-H'221, H224-H'224, H255-H315, H361-H419, H'22-H'96, H'129-L'214, H'142-H'198, H'255-H'315, H'361-H'419, L22-L90, L137-L196, L'22-L'90, L'137-L'196)
  TYPE      Peptide
CLASS       Hypolipidemic agent
             DG01946  Hypolipidemic agent
              DG03128  Anti-PCSK9 antibody and siRNA
REMARK      Therapeutic category: 2189
            ATC code: C10AX13
            Product: D10557<JP/US>
EFFICACY    Antihyperlipidemic, Anti-PCSK9 antibody
  DISEASE   Primary hyperlipidemia [DS:H01635]
            Homozygous familial hypercholesterolemia [DS:H00155]
            Heterozygous familial hypercholesterolemia [DS:H00155]
  TYPE      Monoclonal antibody
TARGET      PCSK9 [HSA:255738] [KO:K13050]
  PATHWAY   hsa04979(255738)  Cholesterol metabolism
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             C CARDIOVASCULAR SYSTEM
              C10 LIPID MODIFYING AGENTS
               C10A LIPID MODIFYING AGENTS, PLAIN
                C10AX Other lipid modifying agents
                 C10AX13 Evolocumab
                  D10557  Evolocumab (USAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Cardiovascular Agents
              Dyslipidemics, PCSK9 Inhibitor
               Evolocumab
                D10557  Evolocumab (USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              21  Cardiovascular agents
               218  Hyperlipidemia agents
                2189  Others
                 D10557  Evolocumab (USAN/INN); Evolocumab (genetical recombination) (JAN)
            Drug groups [BR:br08330]
             Hypolipidemic agent
              DG01946  Hypolipidemic agent
               DG03128  Anti-PCSK9 antibody and siRNA
                D10557  Evolocumab
            Drug classes [BR:br08332]
             Cardiovascular agent
              DG01946  Hypolipidemic agent
               D10557  Evolocumab
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Hydrolases (EC3)
               Serine peptidases
                PCSK9
                 D10557  Evolocumab (USAN/INN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D10557
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10557
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D10557
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D10557
DBLINKS     CAS: 1256937-27-5 1420806-15-0
            PubChem: 254741519
///
